A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
J Pediatr Hematol Oncol
; 44(2): e537-e538, 2022 03 01.
Article
in English
| MEDLINE | ID: covidwho-1197061
ABSTRACT
Patients with hemato-oncologic diseases are particularly vulnerable to severe infections. Adult patients with blood cancers infected with SARS-CoV-2 had poorer treatment outcomes and higher mortality than patients with COVID-19 without burden. However, in pediatric patients with hemato-oncologic diseases the course of COVID-19 is milder than in adults in the same group of patients. In this report, we describe the case of our patient with acute lymphoblastic leukemia infected with SARS-CoV-2 and treated with remdesivir. We also review the existing literature of pediatric patients who have been diagnosed with both hemato-oncologic diseases and COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Adenosine Monophosphate
/
Alanine
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
SARS-CoV-2
/
COVID-19 Drug Treatment
/
Neoplasm Recurrence, Local
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Female
/
Humans
Language:
English
Journal:
J Pediatr Hematol Oncol
Journal subject:
Hematology
/
Neoplasms
/
Pediatrics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS